跳至主要内容
临床试验/NCT05505071
NCT05505071撤回不适用

DANTE SPACE for Evaluation of Subjects With Intracranial Vascular Disease

University of North Carolina, Chapel Hill0 个研究点开始时间: 2022年12月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Clinical Utility for Visualizing Pathology

研究概览

简要总结

Purpose: The purpose of this study is to evaluate the Delay Alternating with Nutation for Tailored Excitation (DANTE) SPACE sequence in clinical studies to determine whether it can provide more useful information for clinical diagnosis.

Participants: 100 participants with concern for intracranial vascular disease scheduled to undergo a clinical vessel wall MRI will be recruited.

Procedures (methods): Patients with concern for intracranial vascular disease scheduled to undergo a clinical vessel wall MRI who will have an additional non-FDA approved sequence (DANTE SPACE) added to their clinical scan. The investigational sequence requires less than 15 minutes and will be added following the standard MRI sequence.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18 and older
  • Concern for intracranial vascular disease
  • Scheduled to undergo a clinical vessel wall MRI

排除标准

  • Claustrophobia
  • Implanted metallic devices, parts, vascular clips, or other foreign bodies.
  • Known hypersensitivity to gadolinium contrast or to any component of gadolinium contrast refractory to standard medications (antihistamines, steroids)
  • Impaired kidney function (serum creatinine level > 1.8 mg/dL or a glomerular filtration rate < 60 as approximated using serum creatinine levels) unless anuric and on dialysis.
  • Any woman who is pregnant or has reason to believe she is pregnant via self report

结局指标

主要结局

Clinical Utility for Visualizing Pathology

时间窗: Baseline

The primary objective is to determine the percent of participants with a visible region of interest.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验